Shrooms in the News Vol. 12: All the Guided Psilocybin Therapy Headlines Fit to Print

Thwap! Yep, that’s the sound of your psychedelic newspaper landing on your doorstep. This month, we herald a new study that shows huge promise for Major Depressive Disorder (MDD), dig into research about psilocybin and smoking cessation, celebrate the psilocybin-paved inroads against cocaine-use disorder and look at some interesting demographic information that reveals just how popular magic mushrooms are.

A New Study Shows Psilocybin Therapy Helps People Quit Smoking

Six months after the psilocybin experiences, those who had taken just one dose of psilocybin had more than six times greater odds of being abstinent from cigarettes than their counterparts who relied on the nicotine substitute.

Another Trial Delivers Positive Results for Psilocybin and Major Depressive Disorder

In this trial, a single dose of psilocybin spawned rapid antidepressant effects, observed by day 2 and persisting for more than 3 months.

Magic Mushrooms are Extremely Effective Against Cocaine Addiction

In this study out of Alabama, 19 participants who received a single dose of psilocybin were found more likely to abstain from cocaine than 17 participants who received a placebo.

Demographic Date Suggests that 2.8% of Americans Use Psilocybin

It turns out that there’s 8 million of us in the United States alone.